158 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Are Investors Undervaluing Cardinal Health (CAH) Right Now? https://www.zacks.com/stock/news/2210749/are-investors-undervaluing-cardinal-health-cah-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2210749 Jan 16, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low Leverage Stocks to Buy on Expectations of Rate Cuts https://www.zacks.com/stock/news/2214297/5-low-leverage-stocks-to-buy-on-expectations-of-rate-cuts?cid=CS-ZC-FT-analyst_blog|rw-2214297 Jan 23, 2024 - The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may buy NSIT, ACA, CAH, PLAB and WING.
Ahead of Cardinal (CAH) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics https://www.zacks.com/stock/news/2217006/ahead-of-cardinal-cah-q2-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2217006 Jan 29, 2024 - Get a deeper insight into the potential performance of Cardinal (CAH) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Medical Device Stocks' Earnings on Feb 1: RVTY, CAH & More https://www.zacks.com/stock/news/2218722/medical-device-stocks-earnings-on-feb-1-rvty-cah-more?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2218722 Jan 31, 2024 - Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how CAH, RVTY, CNMD, SRDX and BDX are placed ahead of their earnings releases.
Are Medical Stocks Lagging Cardinal Health (CAH) This Year? https://www.zacks.com/stock/news/2218740/are-medical-stocks-lagging-cardinal-health-cah-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2218740 Jan 31, 2024 - Here is how Cardinal Health (CAH) and CSL Limited Sponsored ADR (CSLLY) have performed compared to their sector so far this year.
Cardinal Health (CAH) Beats on Q2 Earnings, Ups '24 EPS View https://www.zacks.com/stock/news/2219544/cardinal-health-cah-beats-on-q2-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2219544 Feb 01, 2024 - Cardinal Health's (CAH) second-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.
Here's Why You Should Retain IDEXX (IDXX) Stock for Now https://www.zacks.com/stock/news/2227054/here-s-why-you-should-retain-idexx-idxx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227054 Feb 15, 2024 - Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance
Here's Why Investors Should Retain ResMed (RMD) Stock for Now https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766 Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe https://www.zacks.com/stock/news/2228631/illumina-ilmn-rides-on-ngs-portfolio-expansion-amid-macro-woe?cid=CS-ZC-FT-analyst_blog|zer_report_update-2228631 Feb 20, 2024 - In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.
Medtronic (MDT) Q3 Earnings Beat Estimates, 2024 View Up https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2228769 Feb 20, 2024 - Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.

Pages: 1234567...16

<Page 2>